Aileen Rubio, PhD, is the Head of Biology for Spero Therapeutics in Cambridge, MA. She previously held positions of increasing responsibility at Cubist Pharmaceuticals, where she worked for over 9 years. During that time, she worked on antibacterial discovery projects, as well as provided support for business development activities. She has also collaborated with several key opinion leaders to investigate the mechanism of action/resistance of Cubicin (daptomycin for injection) in Staphylococcus aureus.

Dr. Rubio received BS degrees in both Microbiology and Chemistry from the University of Illinois at Champaign-Urbana, a PhD in Bacteriology from the University of Wisconsin at Madison and completed post-doctoral research at the University of California at San Diego.

Michael Lewinski, Ph.D., D(ABMM), CM, MB(ASCP)^CM is currently the Sr. Director of Medical Affairs, Microbiology and Smarticles technology at Roche Molecular Systems, Inc. in Pleasanton, California. He completed his Doctor of Philosophy degree in Microbiology and Immunology and a clinical postdoctoral Fellowship in Medical and Public Health Laboratory Microbiology at UCLA. He is a Diplomate of the American Board of Medical Microbiology, a licensed Laboratory Director and a certified Molecular Biologist. Prior to joining Roche, he was the Chief of Microbiology and Associate Clinical Professor of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA. Prior to UCLA he was the Senior Scientific Director of Infectious Diseases at Quest Diagnostics Nichols Institute and Focus Diagnostics, Inc. He has served as the President of the Southern California Branch of the American Society for Microbiology, on the Council of the Pan American Society of Clinical Virology and as Chair of the Infectious Disease Subdivision of the Association for Molecular Pathology and he currently serves on the Membership/Nominations Committee of the Pan American Society for Clinical Virology and the Editorial Board of the Journal of Clinical Virology. His research interests have focused on the development and the automation of molecular tests for the detection, quantification, and characterization of microorganisms for the diagnosis of disease and for monitoring disease progression and response to therapy. He holds several patents and has published in various disciplines within infectious diseases and laboratory medicine.

Greg Bleck is Global Head of Research and Development at Catalent Biologics with overall responsibility for development and acquisition of new products and technologies. Greg was an original employee of Gala Biotech (acquired by Catalent), where he used his knowledge of gene expression and transgenic systems to develop and optimize retrovector expression systems and the proprietary GPEx® process.  Prior to joining Gala, Greg performed postdoctoral work at the University of Illinois-Urbana working in the areas of gene regulation and expression. He holds a B.S. and a Ph.D. in Endocrinology-Reproductive Physiology, both from the University of Wisconsin-Madison. Greg has published over 60 research papers, co-authored three book chapters, and is an inventor or co-inventor on eight issued patents and eight patents currently under review.

Ana Hooker serves as Senior Vice President of Operations at Exact Sciences Corporation. Ms. Hooker joined Exact Sciences in 2013. Ms. Hooker oversee all laboratory operations. She served as Vice President and Division Manager of Integrated Oncology and Genetics at RUP Laboratories. Ms. Hooker was President of Utah chapter, Clinical Laboratory Management Association (CLMA); National CLMA; Association of Molecular Pathology (AMP); American Society of Clinical Laboratory Science (ASCLS). She holds an MBA from Westminster College and B.S. from Kansas State University.

Tony Evers was first elected Wisconsin State Superintendent of Public Instruction in April 2009.Tony has dedicated his life to public education in our state, working with the students, parents, and citizens of Wisconsin for more than 38 years as a teacher, principal, superintendent, and regional administrator. Prior to his election, Tony served eight years as the deputy state superintendent of public instruction.. He has served in schools and lived in communities across Wisconsin, from Tomah to Oakfield, Verona to Oshkosh.

Tony Evers has been married 43 years to his wife Kathy; they met in kindergarten. They are the parents of three adult children, all public school graduates, and have six grandchildren.

Dr. Katie Mrdutt (Mir-due-t) is the Food Armor® Program Manager with the Food Armor® Foundation. Dr. Mrdutt’s responsibilities include educating veterinarians, farmers and industry stakeholders on responsible medication use and antimicrobial stewardship in animal agricul-ture. She earned her Bachelor of Science and Veterinary Medical degrees from the University of Minnesota, graduating in 2011 and is currently pursuing a MBA from the University of Wisconsin Eau Claire. Following graduation from veterinary school she went into private practice with an emphasis on dairy production systems. In July of 2014, she joined the Wisconsin Veterinary Medical Association in her current role. The Food Armor® program transitioned from the WVMA to a standalone non-profit foundation in the fall of 2017, now called the Food Armor® Foundation. She currently resides in Western Wisconsin with her husband, 3 children and their herd of beef cows.

Nasia Safdar has been the Medical Director of Infection Control at UW Hospital and Clinics since 2009. She came to Wisconsin in 1997 for her residency and fellowship. She is board certified in infectious disease and she focuses on healthcare-associated infections, particularly in the acute care setting. Dr. Safdar believes that many health care-associated infections can be prevented with adherence to known best practices. As medical director for the department of infection prevention, her job is to lead the department in its mission of reducing healthcare-associated infections by identifying, testing and implementing interventions that have benefit for reducing health care associated infections (HAI).
She is an associate professor of infectious diseases at the University of Wisconsin School of Medicine and Public Health and the Associate Chief of Staff for Research at the William S. Middleton VA Hospital. Her research includes the evaluation of novel and innovative strategies for prevention of HAI. She is currently leading the fecal bacteriotherapy program at UW Hospital and is the principal investigator of a current ongoing VA-funded trial of probiotics for reducing HAI.

Katrina R. Viviano, DVM, PhD, DACVIM, DACVCP is a Clinical Associate Professor in Department of Medical Sciences at University of Wisconsin-Madison, School of Veterinary Medicine. The clinical challenges presented by antimicrobial resistant infections in companion animals drives her clinical interest in antibiotic stewardship and teaching evidence-based prescribing. After receiving her DVM from the University of Wisconsin-Madison, she completed board-certification as a small animal internist and clinical pharmacologist. Her classical training as a PhD organic chemist serves as her foundation and led to her interest in pursuing a career in academic research, which also impacts the lives of her patients. Other clinical interests include toxicology, immune-mediated diseases, and the role of antioxidants in health and disease.

Michael Moll has served as the primary athletic trainer at UW–Madison for a variety of sports including softball, men’s and women’s tennis, women’s basketball and wrestling. From 2003-12 he was an assistant athletic trainer with the football team. From 2012-2017, Moll has served as the Badgers’ head football athletic trainer.
In his role as Assistant Athletic Director of Sports Medicine, Moll will be responsible for developing, coordinating, and administering the overall sports medicine program for UW. He will serve as the athletics’ health care administrator and oversee UW’s athletic health care administration and delivery. That includes directing the development, coordination and delivery of the professional and administrative services essential to the successful implementation of a comprehensive sports medicine program.
Currently the vice president of the Wisconsin Athletic Trainers’ Association, Moll was awarded the WATA Distinguished Service Award in 2007. He is also currently the Wisconsin state representative to the Great Lakes Athletic Trainers’ Association.